SCHEMBL89146

SCHEMBL89146

CCOC(=O)C(Br)C(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
TRPA1 O75762 1/20 0.42
LMNA P02545 1/20 0.42
HSD17B10 Q99714 1/20 0.42
ALOX15 P16050 1/20 0.40
MGAM O43451 1/20 0.40
GAA P10253 1/20 0.40
SI P14410 1/20 0.40
MGAM2 Q2M2H8 1/20 0.40
SOAT1 P35610 1/20 0.40
PIN1 Q13526 1/20 0.34
HPGD P15428 1/20 0.34
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
KMT2A Q03164 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
CAD P27708 1/20 0.33
MMP8 P22894 1/20 0.33
HCAR2 Q8TDS4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1733288 1.00 ALDH1A1 (0.43) ALDH1A1TRPA1LMNAHSD17B10ALOX15
SCHEMBL1731339 1.00 ALDH1A1 (0.43) ALDH1A1TRPA1LMNAHSD17B10ALOX15
SCHEMBL22144315 0.87 ALDH1A1 (0.50) ALDH1A1TRPA1LMNAHSD17B10ALOX15
SCHEMBL1415615 0.87 ALDH1A1 (0.50) ALDH1A1TRPA1LMNAHSD17B10ALOX15
SCHEMBL9834260 0.85 ALDH1A1 (0.43) ALDH1A1TRPA1LMNAHSD17B10ALOX15
SCHEMBL9753730 0.83 ALDH1A1 (0.42) ALDH1A1TRPA1LMNAHSD17B10ALOX15
SCHEMBL6157334 0.83 ALDH1A1 (0.42) ALDH1A1TRPA1LMNAHSD17B10ALOX15
SCHEMBL23255902 0.81 ALDH1A1 (0.40) ALDH1A1TRPA1LMNAHSD17B10ALOX15
SCHEMBL6581296 0.81 ALDH1A1 (0.40) ALDH1A1TRPA1LMNAHSD17B10ALOX15
SCHEMBL10867163 0.80 ALDH1A1 (0.43) ALDH1A1TRPA1LMNAHSD17B10ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 664 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115959993-B Synthesis method of 2-aryl propionic acid compound 山东中医药大学 2025-01-07 CN claimed
CN-116283648-B Substituted benzene acryloyl or benzene propionyl phenethylamine compound and preparation method and application thereof 中国医学科学院药用植物研究所 2024-03-19 CN claimed
CN-116283648-A Substituted benzene acryloyl or benzene propionyl phenethylamine compound and preparation method and application thereof 中国医学科学院药用植物研究所 2023-06-23 CN claimed
CN-115959993-A Synthetic method of 2-aryl propionic acid compound 山东中医药大学 2023-04-14 CN claimed
CN-107560897-B Single-person adjustable vertical water sampling method 浙江海洋大学 2020-06-16 CN claimed
CN-110066835-A A kind of application of lipase in resolution of racemic 2- bromo ethyl isovalerate 浙江工业大学 2019-07-30 CN claimed
EP-2399902-B1 PROCESS FOR PREPARING 2,3-DI-NON-STRAIGHT-ALKYL-2-CYANO SUCCINIC ACID DIESTERS CHINA PETROLEUM & CHEMICAL (CN) 2014-11-26 EP claimed
US-8669392-B2 Process for preparing 2,3-di-non-straight-alkyl-2-cyanosuccinic acid diesters CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2014-03-11 US claimed
US-20120046490-A1 PROCESS FOR PREPARING 2,3-DI-NON-STRAIGHT-ALKYL-2-CYANOSUCCINIC ACID DIESTERS CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2012-02-23 US claimed
EP-2399902-A1 PROCESS FOR PREPARING 2,3-DI-NON-STRAIGHT-ALKYL-2-CYANO SUCCINIC ACID DIESTERS China Petroleum & Chemical Corporation (CN) 2011-12-28 EP claimed
US-20260144788-A1 COMPOUND FOR SHP2 PROTEIN DEGRADATION AND MEDICAL USES THEREOF UBIX THERAPEUTICS, INC. (KR) 2026-05-28 US disclosed
US-12617802-B2 Sulfonimidamide compounds as NLRP3 modulators GENENTECH, INC. (US) 2026-05-05 US disclosed
WO-2026090330-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2026-04-30 WO disclosed
EP-4711368-A1 AZEPINE COMPOUND, AND COMPOSITION AND USE THEREOF CHENGDU MFS PHARMA. CO., LTD. (CN) 2026-03-18 EP disclosed
EP-3773573-B1 ANTAGONISTS OF HUMAN INTEGRIN (ALPHA4)(BETA7) MORPHIC THERAPEUTIC INC (US) 2026-03-18 EP disclosed
EP-0066217-A1 Novel substituted nitrodiphenyl ethers, herbicidal compositions containing them, processes for the preparation thereof and the use thereof for combating weeds ROHM AND HAAS COMPANY (US) 1982-12-08 EP disclosed
US-4304788-A ANTIARTHRITIC AGENTS IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1981-12-08 US disclosed
EP-0020052-A1 Novel substituted nitrodiphenyl ethers, herbicidal compositions containing them, processes for the preparation thereof and the use thereof for combating weeds ROHM AND HAAS COMPANY (US) 1980-12-10 EP disclosed
US-4089672-A HERBICIDES THE UPJOHN COMPANY (US) 1978-05-16 US disclosed
US-4084955-A 1-CARBOXYALKYL-DI- AND TRIHALOPYRAZOLES, HERBICIDES THE UPJOHN COMPANY (US) 1978-04-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046490-A1 PROCESS FOR PREPARING 2,3-DI-NON-STRAIGHT-ALKYL-2-CYANOSUCCINIC ACID DIESTERS ACMSD, ADSL, CNDP2 ALDH1A1 1240/4885TRPA1 4644/4885LMNA 479/4885
US-20260144788-A1 COMPOUND FOR SHP2 PROTEIN DEGRADATION AND MEDICAL USES THEREOF PTPN6, PTPN1, PTPN11 ALDH1A1 3337/4885TRPA1 2946/4885LMNA 4730/4885
US-12617802-B2 Sulfonimidamide compounds as NLRP3 modulators NLRP3, NLRP1, PYCARD ALDH1A1 2022/4885TRPA1 53/4885LMNA 2411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.